Indian stocks: Visit www.stage2stocks.com →

NewGenIvf Group Limited Class A

Stage 4 · Declining · week 97

As of Oct 22, 2026, NewGenIvf Group is in Stage 4, the downtrend phase, now in week 97 (since Nov 14, 2024). It closed at $0.15, 100.0% below its 52-week high and below its 200-day average, which is falling.

NewGenIvf Group Limited, an investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan. More about the company

$0.15
-20.74% today
$1.0M · Micro cap
Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Steady

Edge

—

Is NIVF early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2023-08-16 → 2026-10-22
S2 28w
S4 30w
S4 101w
2023-08-162026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S2 28w → S3 3w → S4 30w → S1 3w → S4 101w current
Total tracked: 166 weeks across 5 stage runs.

NIVF among Medical Care Facilities46th of 49 by relative strength

All 49 →
Stocks in Medical Care Facilities ranked by relative strength, with stage and one-month change
#StockStageRS1M
1AGLStage 3 · wk 898+6.8%
2PACSStage 3 · wk 498+15.7%
3LFSTStage 2 · wk 2497+4.0%
4AMNStage 2 · wk 2596+38.1%
5NHCStage 2 · wk 5995+8.4%
6CONStage 2 · wk 2294+14.9%
7INNVStage 3 · wk 593+5.8%
8MDStage 2 · wk 2692+14.3%
…46NIVFStage 4 · wk 971−93.7%
vs 52W High
-100.0%
$0.15 lo$2,825.28 hi
100.0% below 52W high, deep Stage 4 damage
In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.
Stage Maturity
Week 97
1w13w26w
Week 97, extended decline
How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.
vs 200 DMA
-99.7%
200 DMA: $57.09 · sloping down
In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.
Rel Volume
0.21x
vs 50-day avg
High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.
Trend Health
↓
Short-term trend rolling over
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
-93.7%
3M
-98.9%
6M
-99.8%
YTD
-99.9%
1Y
-100.0%
Scan Membership
Breakout Watch
Latest: 2023-01-03
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-22S4
Wk 97 · Vol 0.21x
2026-10-21S4
Wk 97 · Vol 1.19x
2026-10-20S4
Wk 97 · Vol 0.18x
2026-10-19S4
Wk 97 · Vol 0.23x
2026-10-16S4
Wk 97 · Vol 1.70x
2026-10-15S4
Wk 96 · Vol 0.60x
2026-10-14S4
Wk 96 · Vol 25.60x
2026-10-13S4
Wk 96 · Vol 0.26x
2026-10-12S4
Wk 96 · Vol 0.93x
2026-10-09S4
Wk 96 · Vol 0.61x
2026-10-08S4
Wk 95 · Vol 0.67x
2026-10-07S4
Wk 95 · Vol 6.02x
Moving averages & range
50 DMA
$3.11
200 DMA
$57.09
52W High
$2,825.28
52W Low
$0.15
5D Low
$0.15
Resistance levels (recent highs)
20d High
$2.24
60d High
$10.20
120d High
$60.84
250d High
$2,635.20
Next resistance
+1403.4%
to 20d High
ROE
+5.5%
Profit margin +24.2%
Dividend Yield
0.00%
P/B 0.0

NewGenIvf Group: quick answers

What stage is NewGenIvf Group in?

As of Oct 22, 2026, NewGenIvf Group (NIVF) is in Stage 4, the downtrend phase. It entered Stage 4 on Nov 14, 2024 and is in week 97. What the four stages mean

Is NewGenIvf Group in an uptrend?

No. NewGenIvf Group is in a Stage 4 downtrend. It trades 99.7% below its 200-day average, which is falling.

How far is NewGenIvf Group from its 52-week high?

NewGenIvf Group closed at $0.15 on Oct 22, 2026, 100.0% below its 52-week high of $2,825.28. Its 52-week low is $0.15.

How has NewGenIvf Group performed over the past year?

As of Oct 22, 2026, NewGenIvf Group is down 100.0% over the past year and down 99.9% so far in 2026.

Which sector and industry is NewGenIvf Group in?

NewGenIvf Group is in the Medical Care Facilities industry, part of the Health Care sector.

About this companyHealth Care· Medical Care Facilities

NewGenIvf Group Limited, an investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan. The company provides a range of fertility treatment solutions, including in vitro fertilization (IVF), ICSI, embryo culture, hormonal blood tests, infectious diseases tests, chromosome screening, hysteroscopy, sperm analysis, sorting, washing, and freezing, and egg freezing. It also offers IVF treatment; surrogacy and ancillary caring services, and value-added services comprising nutrition guidance, psychological counselling, acupuncture, and translation interpreters to supplement the IVF treatment. The company provides its services through clinics. NewGenIvf Group Limited was founded in 2010 and is based in Bangkok, Thailand.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.